Phreesia, Inc. (NYSE:PHR) Shares Bought by Hsbc Holdings PLC

Hsbc Holdings PLC raised its stake in shares of Phreesia, Inc. (NYSE:PHR) by 36.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 13,064 shares of the company’s stock after acquiring an additional 3,493 shares during the period. Hsbc Holdings PLC’s holdings in Phreesia were worth $333,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. R Squared Ltd purchased a new position in Phreesia in the 4th quarter valued at approximately $30,000. BankPlus Trust Department purchased a new position in Phreesia in the fourth quarter valued at $34,000. Venturi Wealth Management LLC acquired a new position in Phreesia during the 4th quarter worth $76,000. Smartleaf Asset Management LLC increased its holdings in Phreesia by 154.6% during the 4th quarter. Smartleaf Asset Management LLC now owns 3,442 shares of the company’s stock worth $89,000 after purchasing an additional 2,090 shares during the period. Finally, NewEdge Advisors LLC increased its holdings in Phreesia by 12.1% during the 4th quarter. NewEdge Advisors LLC now owns 4,256 shares of the company’s stock worth $107,000 after purchasing an additional 459 shares during the period. 92.10% of the stock is owned by hedge funds and other institutional investors.

Phreesia Stock Performance

Shares of PHR stock opened at $25.34 on Friday. The company has a market cap of $1.49 billion, a P/E ratio of -17.24 and a beta of 0.74. The business has a 50 day moving average of $25.08 and a two-hundred day moving average of $24.64. Phreesia, Inc. has a 52 week low of $17.07 and a 52 week high of $30.53. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the company. Canaccord Genuity Group raised their price target on Phreesia from $34.00 to $35.00 and gave the company a “buy” rating in a research note on Thursday, March 13th. DA Davidson decreased their target price on Phreesia from $36.00 to $34.00 and set a “buy” rating for the company in a research note on Monday, April 14th. KeyCorp dropped their price target on shares of Phreesia from $30.00 to $28.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 16th. Needham & Company LLC restated a “buy” rating and set a $29.00 price objective on shares of Phreesia in a research report on Thursday, March 13th. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $33.00 target price (up from $31.00) on shares of Phreesia in a research report on Wednesday, January 29th. Twelve equities research analysts have rated the stock with a buy rating, According to MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $31.33.

Insiders Place Their Bets

In other Phreesia news, SVP David Linetsky sold 4,499 shares of the firm’s stock in a transaction dated Wednesday, April 16th. The stock was sold at an average price of $23.73, for a total transaction of $106,761.27. Following the completion of the sale, the senior vice president now directly owns 217,239 shares in the company, valued at approximately $5,155,081.47. This trade represents a 2.03 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, COO Evan Roberts sold 3,519 shares of the firm’s stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $30.06, for a total transaction of $105,781.14. Following the sale, the chief operating officer now owns 741,197 shares of the company’s stock, valued at approximately $22,280,381.82. This represents a 0.47 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 111,640 shares of company stock worth $3,094,167. Insiders own 5.80% of the company’s stock.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.